Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Physiol Pharmacol ; 58(1): 95-103, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17440229

RESUMEN

We tested whether simulation of postural changes, which occur during public speech test procedures, activates cardiovascular system and stress hormone release that could interfere with the effect of psychosocial stress load. Young healthy male volunteers (n=8) underwent procedure imitating exactly all postural changes present in the psychosocial stress model based on public speech used in this laboratory (namely changes from sitting to standing and repeated sitting). Postural changes were associated with increases in heart rate, blood pressure, plasma concentrations of noradrenaline and aldosterone and elevation in plasma renin activity. In contrast to cardiovascular parameters, adrenocorticotropic hormone, cortisol and adrenaline, the main characteristics of hormonal response during mental stress, were not significantly influenced. The overall magnitude of all observed alterations was much smaller than that seen following mental stress procedures in our previous studies. This study provides evidence that changes in body posture during public speech test procedure influence hemodynamics and endocrine responses in a mild manner. Though this influence may represent a source of unspecific variance, substantial confounding effects on responses to the psychosocial component of the procedure are unlikely. In any case, models combining mental stressors and changes in body posture must be interpreted as complex stress stimuli.


Asunto(s)
Sistema Cardiovascular , Hormonas/sangre , Postura , Habla , Estrés Psicológico/fisiopatología , Hormona Adrenocorticotrópica/sangre , Adulto , Aldosterona/sangre , Presión Sanguínea , Epinefrina/sangre , Frecuencia Cardíaca , Humanos , Hidrocortisona/sangre , Masculino , Modelos Psicológicos , Norepinefrina/sangre , Renina/sangre , Saliva/metabolismo , Índice de Severidad de la Enfermedad , Estrés Psicológico/sangre , Factores de Tiempo
2.
Horm Behav ; 51(3): 395-405, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17258216

RESUMEN

Vasopressin, a peptide hormone functioning also as a neurotransmitter, neuromodulator and regulator of the stress response is considered to be one of the factors related to the development and course of depression. In the present study, we have tested the hypothesis that congenital deficit of vasopressin in Brattleboro rats leads to attenuated depression-like behavior in tests modeling different symptoms of depression. In addition, hypothalamic-pituitary-adrenocortical axis activity was investigated. Vasopressin deficient rats showed signs of attenuated depression-like behavior in forced swimming and sucrose preference tests, while their behavior on elevated plus maze was unchanged. Vasopressin deficiency had no influence on basal levels of ACTH and corticosterone and had only mild impact on hormonal activation in response to forced swimming and plus-maze exposure. However, vasopressin deficient animals showed higher level of dexamethasone induced suppression of corticosterone response to restraint stress and higher basal levels of corticotropin-releasing hormone mRNA in the hypothalamic paraventricular nucleus. In conclusion, present data obtained in vasopressin deficient rats show that vasopressin is involved in the development of depression-like behavior, in particular of the coping style and anhedonia. Moreover, behavioral and endocrine responses were found to be dissociated. We suggest that brain vasopressinergic circuits distinct from those regulating the HPA axis are involved in generating depression-like behavior.


Asunto(s)
Conducta Animal/fisiología , Depresión/patología , Vasopresinas/deficiencia , Adaptación Psicológica , Hormona Adrenocorticotrópica/sangre , Hormona Adrenocorticotrópica/metabolismo , Animales , Corticosterona/sangre , Diabetes Insípida/sangre , Diabetes Insípida/patología , Preferencias Alimentarias , Sistema Hipotálamo-Hipofisario/fisiopatología , Masculino , Aprendizaje por Laberinto , Sistema Hipófiso-Suprarrenal/fisiopatología , Ratas , Ratas Brattleboro , Natación , Vasopresinas/sangre
3.
J Physiol Pharmacol ; 54(3): 329-38, 2003 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-14566072

RESUMEN

Stress is considered to be a risk factor of several diseases. The following hypotheses were tested: (1) single exposure to an intensive stressor is followed by endothelial stimulation and/or damage to endothelial cells, (2) potential stress-induced endothelial cell damage is reduced by repeated pretreatment with pentoxifylline and (3) pentoxifylline treatment modifies neuroendocrine activation during stress reflected by changes in hypothalamic-pituitary-adrenocortical (HPA) axis function. Rats were treated with saline or pentoxifylline (20 mg/kg, s.c.) once daily for 7 days and then exposed to single immobilization stress for 20 or 120 min. In saline pretreated rats, stress exposure was followed by a rise in endothelaemia, von Willebrand factor concentrations, adrenocorticotropic hormone (ACTH) and corticosterone release, as well as by enhanced gene expression of hypothalamic corticotropin releasing factor (CRH). Stress-induced changes were reduced by pretreatment with pentoxifylline. Significant inhibition was observed in endothelaemia, plasma ACTH and corticosterone concentration in the adrenals. Thus, signs of endothelial injury as well as stress-induced hormone levels were reduced by pretreatment with pentoxifylline, although there is no evidence for a causal relationship. This protective action of pentoxifylline might be of benefit in the prevention and therapy of some stress-related disorders.


Asunto(s)
Células Endoteliales/efectos de los fármacos , Sistema Hipotálamo-Hipofisario/metabolismo , Pentoxifilina/uso terapéutico , Sistema Hipófiso-Suprarrenal/metabolismo , Estrés Fisiológico/metabolismo , Factor de von Willebrand/metabolismo , Glándulas Suprarrenales/química , Glándulas Suprarrenales/efectos de los fármacos , Glándulas Suprarrenales/metabolismo , Hormona Adrenocorticotrópica/antagonistas & inhibidores , Hormona Adrenocorticotrópica/sangre , Animales , Corticosterona/sangre , Hormona Liberadora de Corticotropina/biosíntesis , Hormona Liberadora de Corticotropina/sangre , Hormona Liberadora de Corticotropina/genética , Esquema de Medicación , Células Endoteliales/metabolismo , Células Endoteliales/patología , Expresión Génica/genética , Sistema Hipotálamo-Hipofisario/efectos de los fármacos , Inmovilización , Inyecciones Subcutáneas , Masculino , Núcleo Hipotalámico Paraventricular/química , Núcleo Hipotalámico Paraventricular/efectos de los fármacos , Pentoxifilina/administración & dosificación , Pentoxifilina/farmacocinética , Sistema Hipófiso-Suprarrenal/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Estrés Fisiológico/tratamiento farmacológico , Estrés Fisiológico/fisiopatología , Factores de Tiempo , Factor de von Willebrand/antagonistas & inhibidores , Factor de von Willebrand/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA